WILLUDA; Jorg

Patent Applications and Registrations

Patent applications and USPTO patent grants for WILLUDA; Jorg.The latest application filed is for "pharmaceutical combination of anti-ceacam6 and either anti-pd-1 or anti-pd-l1 antibodies for the treatment of cancer".

Company Profile

0.7.23

WILLUDA; Jorg - Glienicke/Nordbahn DE
WILLUDA; Jorg - Berlin DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Pharmaceutical Combination Of Anti-ceacam6 And Either Anti-pd-1 Or Anti-pd-l1 Antibodies For The Treatment Of Cancer App 20220010017 - WILLUDA; Jorg ; et al.	2022-01-13
Anti-ceacam6 Antibodies And Uses Thereof App 20200181261 - WILLUDA; Jorg ; et al.	2020-06-11
Anti-ceacam6 Antibodies And Uses Thereof App 20200157214 - WILLUDA; Jorg ; et al.	2020-05-21
Anti-CEACAM6 antibodies and uses thereof Grant 10,584,167 - Willuda , et al.	2020-03-10
Anti-ceacam6 Antibodies And Uses Thereof App 20180162940 - WILLUDA; Jorg ; et al.	2018-06-14
Anti-c4.4a Antibodies And Uses Thereof App 20170158775 - LINDEN; Lars ; et al.	2017-06-08
New Binder-drug Conjugates (adcs) And Use Thereof App 20160193359 - LERCHEN; Hans-Georg ; et al.	2016-07-07
NOVEL BINDER-DRUG CONJUGATES (ADCs) AND USE OF SAME App 20150246136 - LERCHEN; Hans-Georg ; et al.	2015-09-03
Binder-drug conjugates (ADCs) and use thereof Grant 8,992,932 - Lerchen , et al. March 31, 2	2015-03-31
Novel Binder-drug Conjugates (adcs) And Use Thereof App 20150030618 - LERCHEN; Hans-Georg ; et al.	2015-01-29
Novel Binder-Drug Conjugates (ADCs) and Use of Same App 20140127240 - Lerchen; Hans-Georg ; et al.	2014-05-08
New Binder-drug Conjugates (adcs) And Use Thereof App 20130122024 - LERCHEN; Hans-Georg ; et al.	2013-05-16
New Binder-drug Conjugates (adcs) And Use Thereof App 20130066055 - Lerchen; Hans-Georg ; et al.	2013-03-14
Anti-c4.4a Antibodies And Uses Thereof App 20120321619 - Linden; Lars ; et al.	2012-12-20
Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment Grant 8,137,932 - Pluckthun , et al. March 20, 2	2012-03-20
Novel Method for the Stabilization of Chimeric Immunoglobulins or Immunoglobulin Fragments, and Stabilized Anti-EGP-2 SCFV Fragment App 20110136173 - PLUCKTHUN; ANDREAS ; et al.	2011-06-09
Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment Grant 7,858,088 - Pluckthun , et al. December 28, 2	2010-12-28
Anti Ephb4 Antibodies And Antibody Fragments App 20090137002 - PETRUL; Heike ; et al.	2009-05-28
Novel Method For The Stabilization Of Chimeric Immunoglobulin Or Immunoglobulin Fragments And, And Stabilized Anti-egp-2 Scfv Fragment App 20080299124 - Pluckthun; Andreas ; et al.	2008-12-04
New effector conjugates, process for their production and their pharmaceutical use App 20080166362 - Berger; Markus ; et al.	2008-07-10
Effector conjugates, process for their production and their pharmaceutical use Grant 7,335,775 - Berger , et al. February 26, 2	2008-02-26
New effector conjugates, process for their production and their pharmaceutical use App 20070088060 - Berger; Markus ; et al.	2007-04-19
Effector conjugates, process for their production and their pharmaceutical use Grant 7,129,254 - Berger , et al. October 31, 2	2006-10-31
Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment App 20060159683 - Pluckthun; Andreas ; et al.	2006-07-20
Method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment Grant 7,033,798 - Pluckthun , et al. April 25, 2	2006-04-25
New effector conjugates, process for their production and their pharmaceutical use App 20050026971 - Berger, Markus ; et al.	2005-02-03
Novel method for the stabilization of chimeric immunoglobulins or immunoglobulin fragments, and stabilized anti-EGP-2 scFv fragment App 20020146846 - Pluckthun, Andreas ; et al.	2002-10-10

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.